Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/30/1996 | WO1996016169A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
05/30/1996 | WO1996016163A2 Embryonal cardiac muscle cells, their preparation and their use |
05/30/1996 | WO1996016087A1 G-protein coupled receptor |
05/30/1996 | WO1996016084A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
05/30/1996 | WO1996016082A1 Novel polypeptides |
05/30/1996 | WO1996016075A1 Antibiotic cryptdin peptides and methods of their use |
05/30/1996 | WO1996016074A1 Double-stranded oligonucleotide and carcinostatic agent containing the same as active ingredient |
05/30/1996 | WO1996015812A1 Use of neuregulins as modulators of cellular communication |
05/30/1996 | WO1996015811A1 Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand |
05/30/1996 | WO1996015807A1 Sperm as vaccine vectors |
05/30/1996 | WO1996015806A1 Human choline acetyltransferase |
05/30/1996 | WO1996015804A1 Acylated insulin analogs |
05/30/1996 | WO1996015802A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
05/30/1996 | WO1996015799A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
05/30/1996 | WO1996015780A1 Compositions and methods for preventing and treating allograft rejection |
05/30/1996 | WO1996015779A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
05/30/1996 | WO1996015778A1 Polynucleotide compositions |
05/30/1996 | WO1996015777A1 Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
05/30/1996 | WO1996015758A2 Methods for stimulating erythropoiesis using thrombopoietin |
05/30/1996 | WO1996015662A1 Enhancing growth and pearl production in mollusks |
05/30/1996 | WO1996012807A3 Hepatitis e virus antigens and uses therefor |
05/30/1996 | WO1996005300A3 Or-1 on orphan receptor belonging to the nuclear receptor family |
05/30/1996 | DE4444460A1 Verfahren zur Steigerung des Ertrags sowie zur Veränderung des Blühverhaltens bei Pflanzen A method of increasing the yield as well as changing the flowering behavior of plants |
05/30/1996 | DE4442419A1 Solar mirror e.g. for photosynthetic solar energy conversion, and for supplying solar cells with radiant solar energy |
05/30/1996 | DE4442179A1 Pathogenresistente Pflanzen und Verfahren zu ihrer Herstellung Pathogen-resistant plants and methods for their preparation |
05/30/1996 | CA2205807A1 Fusion proteins with cytotoxic activity against cells overexpressing erbb2-4 |
05/30/1996 | CA2205593A1 Enzyme gene therapy catalysing prodrug extracellular conversion |
05/30/1996 | CA2205540A1 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
05/30/1996 | CA2205486A1 Polynucleotide compositions |
05/30/1996 | CA2205356A1 Modified proteinase inhibitors |
05/30/1996 | CA2205204A1 Production of variant nisin |
05/30/1996 | CA2205130A1 Immunogens for stimulating mucosal immunity |
05/30/1996 | CA2205060A1 Acylated insulin analogs |
05/30/1996 | CA2204995A1 Antibiotic cryptdin peptides and methods of their use |
05/30/1996 | CA2204850A1 Use of neuregulins as modulators of cellular communication |
05/30/1996 | CA2204524A1 Toxins from the wasp bracon hebetor |
05/30/1996 | CA2204438A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
05/30/1996 | CA2204252A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
05/30/1996 | CA2181826A1 Modulators of anchoring protein function |
05/29/1996 | EP0714026A2 Method for the analytical separation of viruses |
05/29/1996 | EP0713921A2 Methods for in-solution quenching of fluorescently labeled oligonucleotide probes |
05/29/1996 | EP0713920A2 Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid |
05/29/1996 | EP0713916A2 A recombinant beta-amylase |
05/29/1996 | EP0713915A1 Hog cholera virus vaccine and diagnostic |
05/29/1996 | EP0713914A2 A regulatory gene for the expression of nitrile hydratase gene |
05/29/1996 | EP0713913A2 Improved transcription assay |
05/29/1996 | EP0713705A1 Novel anti-hiv drug |
05/29/1996 | EP0713535A1 Dna sequencing enzymes |
05/29/1996 | EP0713532A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
05/29/1996 | EP0713531A1 Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants |
05/29/1996 | EP0713530A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
05/29/1996 | EP0713529A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY |
05/29/1996 | EP0713528A1 $i(IN SITU) EXTRACTION OF MICROBIAL DNA |
05/29/1996 | EP0713496A1 Fibrin-targeted inhibitors of thrombin |
05/29/1996 | EP0713495A1 Methods of enhancing bioactivity of chemokines |
05/29/1996 | EP0713494A1 Method of nucleic acid sequence selection |
05/29/1996 | EP0713493A1 Production of human hemoglobin in transgenic pigs |
05/29/1996 | EP0713423A1 Composite biological-molecule-accretion material |
05/29/1996 | EP0713398A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS |
05/29/1996 | EP0679089A4 Methods for promoting cartilage matrix formation. |
05/29/1996 | EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method |
05/29/1996 | EP0469065B1 Recombinant antibody-toxin fusion protein |
05/29/1996 | EP0401362B1 Cho cells producing enzymatically active recombinant glucocerebrosidase |
05/29/1996 | EP0386086B1 Method for cell poration and cell fusion using radiofrequency electrical pulses |
05/29/1996 | CN1123560A Biological control agents containing mollusc toxins |
05/29/1996 | CN1123326A Modified gene of human tumor necrotizing factor and its production process |
05/29/1996 | CN1123325A Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural N-terminal sequence |
05/29/1996 | CN1123185A Immune couplet |
05/29/1996 | CN1031893C A mutant of protein for basic fibroblast growth factor, DNA and use thereof |
05/29/1996 | CN1031892C Expression of human proapolipoprotein A-I |
05/28/1996 | US5521955 Method for quantitatively determining bone mineral mass by CT system |
05/28/1996 | US5521302 Nucleophilic reaction of phosphate groups |
05/28/1996 | US5521300 Oligonucleotides complementary to mycobacterial nucleic acids |
05/28/1996 | US5521297 Nucleic acids encoding human metabotropic glutamate receptors |
05/28/1996 | US5521296 Glycoprotein and gene coding therefor |
05/28/1996 | US5521295 Nucleic acids encoding hybrid receptor molecules |
05/28/1996 | US5521291 Adenovirus conjugates for gene therapy |
05/28/1996 | US5521288 CD28IG fusion protein |
05/28/1996 | US5521286 Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
05/28/1996 | US5521221 Retro-α-retinol (4,14-retro-retinol) derivatives and uses of retro-α-retinol |
05/28/1996 | US5521153 Synergistic antifungal protein and compositions containing same |
05/28/1996 | US5521093 Genetic engineering process for hirudin |
05/28/1996 | US5521088 Dna fragment sequences for genetic engineering |
05/28/1996 | US5521086 Secretion sequence for the production of a heterologous protein in yeast |
05/28/1996 | US5521084 Bovine heat shock promoter and uses thereof |
05/28/1996 | US5521081 DNA molecule encoding prokaryotic prolylendopeptidase |
05/28/1996 | US5521078 Genetically engineering cotton plants for altered fiber |
05/28/1996 | US5521077 Generalized recombination |
05/28/1996 | US5521076 Modified hepatocytes and uses therefor |
05/28/1996 | US5521072 Vaccines |
05/28/1996 | US5521071 Soluble LDL receptor and gene |
05/28/1996 | US5521070 DNA sequence coding for human factor IX or a similar protein, expression vector, transformed cells, method for preparing factor IX and corresponding products obtained |
05/28/1996 | US5521066 Periplasmic membrane-bound system for detecting protein-protein interactions |
05/28/1996 | US5520913 Tissue plasminogen activator having zymogenic properties |
05/28/1996 | US5520911 Asparagine amino acid at position 105 and serine or threonine at position 107 in polypeptides |
05/28/1996 | US5520899 Process for preparing boron, aluminum, and phosphorus silicates for purification of DNA |
05/28/1996 | CA1338349C Method of inducing lysine overproduction in plants |
05/23/1996 | WO1996015452A1 METHODS FOR AIDING IN THE DIAGNOSIS OF ALZHEIMER'S DISEASE BY MEASURING AMYLOID-β PEPTIDE (X- ≥41) AND TAU |
05/23/1996 | WO1996015273A1 Method for identifying protective antigens for eliciting neutralizing antibodies |
05/23/1996 | WO1996015270A1 Self-quenching fluorescence probe and method |